Impact of the c-MybE308G mutation on mouse myelopoiesis and dendritic cell development by Papathanasiou, Peter et al.
Bond University
Research Repository
Impact of the c-MybE308G mutation on mouse myelopoiesis and dendritic cell development
Papathanasiou, Peter; Petvises, Sawang; Hey, Ying Ying; Perkins, Andrew C.; O'Neill, Helen
C
Published in:
PLoS One
DOI:
10.1371/journal.pone.0176345
Published: 01/04/2017
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Papathanasiou, P., Petvises, S., Hey, Y. Y., Perkins, A. C., & O'Neill, H. C. (2017). Impact of the c-MybE308G
mutation on mouse myelopoiesis and dendritic cell development. PLoS One, 12(4), e0176345. [e0176345].
https://doi.org/10.1371/journal.pone.0176345
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 10 May 2019
RESEARCH ARTICLE
Impact of the c-MybE308G mutation on mouse
myelopoiesis and dendritic cell development
Peter Papathanasiou1, Sawang Petvises1, Ying-Ying Hey1, Andrew C. Perkins2, Helen
C. O’Neill3*
1 Research School of Biology, Australian National University, Canberra ACT, Australia, 2 Mater Research,
Translational Research Institute, University of Queensland, Brisbane QLD, Australia, 3 Clem Jones
Research Centre for Regenerative Medicine, Faculty of Health Sciences and Medicine, Bond University, Gold
Coast QLD, Australia
* honeill@bond.edu.au
Abstract
Booreana mice carrying the c-Myb308G point mutation were analyzed to determine changes
in early hematopoiesis in the bone marrow and among mature cells in the periphery. This
point mutation led to increased numbers of early hematopoietic stem and progenitor cells
(HSPCs), with a subsequent reduction in the development of B cells, erythroid cells, and
neutrophils, and increased numbers of myeloid cells and granulocytes. Myelopoiesis was
further investigated by way of particular subsets affected. A specific question addressed
whether booreana mice contained increased numbers of dendritic-like cells (L-DC subset)
recently identified in the spleen, since L-DCs arise in vitro by direct differentiation from
HSPCs co-cultured over splenic stroma. The non-lethal c-Myb mutation in booreana mice
was associated with significantly lower representation of splenic CD8- conventional dendritic
cells (cDCs), inflammatory monocytes, and neutrophils compared to wild-type mice. This
result confirmed the bone marrow origin of progenitors for these subsets since c-Myb is
essential for their development. Production of L-DCs and resident monocytes was not
affected by the c-MybE308G mutation. These subsets may derive from different progenitors
than those in bone marrow, and are potentially established in the spleen during embryogen-
esis. An alternative explanation may be needed for why there was no change in CD8+ cDCs
in booreana spleen since these cells are known to derive from common dendritic progenitors
in bone marrow.
Introduction
Hematopoiesis is the generation of fully differentiated blood cells from self-renewing hemato-
poietic stem cells (HSCs). There are two waves of hematopoiesis in mice: primitive hematopoi-
esis occurs in the yolk sac from embryonic day 8 (E8) [1], while definitive hematopoiesis is
initiated by HSCs residing in the hematogenic endothelium of the aorta-gonado-mesonephros
(AGM) region appearing at E10.5 [2–4]. Definitive HSCs migrate to the fetal liver where they
expand and differentiate from E12.5 [5]. HSCs then migrate to the bone marrow at E14.5,
which becomes the major site for hematopoiesis throughout adult life [5]. HSCs also migrate
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to the spleen at E14.5, although hematopoiesis in spleen is mostly restricted to the production
of erythrocytes [6].
The development of hematopoietic lineages is tightly regulated by transcription factors.
Some of these play dual roles in primitive and definitive hematopoiesis, while others are rela-
tively specific to definitive hematopoiesis. For example, Scl/Tal and Gata2 are essential for
both primitive and definitive hematopoiesis [7, 8], while c-Myb is crucial only for definitive
[9]. The c-Myb gene encodes a transcription factor that is part of a complex genetic network
crucial for maintaining self-renewing hematopoietic stem/progenitor cells (HSPCs) and regu-
lating their differentiation [9]. Most genetic studies of c-Myb function have been conducted in
mouse models, although most mutations are embryonic lethal [10]. C-Myb plays an important
role in HSPC self-renewal since conditional knockouts show a loss of stem cells and an acceler-
ated differentiation of hematopoietic progeny [11].
We identified c-Myb mutation in a strain called booreana (c-MybE308G: boo) by screening
for hematopoietic phenotypes in embryos following the mutagenesis of adult sperm with ethyl-
nitrosourea (ENU) [12]. Mice with the c-MybE308G mutation were not embryonic lethal, with
homozygous boo/boo mice surviving to adulthood. An initial analysis of HSPCs in the fetal
liver of boo/boo compared with wild-type (WT) mice revealed an increase in HSCs with long-
term reconstituting capacity (LT-HSCs), multipotential progenitors (MPPs), and common
lymphoid progenitors (CLPs) [12]. A more variable effect was seen on common myeloid pro-
genitors (CMPs), with a decrease in granulocyte-macrophage progenitors (GMPs). This was
consistent with findings using a c-MybM303V mutant strain that showed increased numbers of
HSCs, CLPs and CMPs [9]. Booreana mice (c-MybE308G) harbored a single amino acid change
in the transactivation domain of c-Myb [12]. Like the M303V mutation, the E308G mutation
prevented interaction of the c-MYB protein with its co-activator p300, and led to a complete
block in the transactivation capacity of c-MYB and substantial changes in hematopoiesis [9,
13]. An initial study on booreana mice showed decreased B lymphopoiesis, increased megakar-
yopoiesis, and increased numbers of red blood cells, neutrophils and myeloid/dendritic cells
(DC) in the blood [12]. Previously, a conditional knockout mouse study indicated a critical
role for c-Myb in the self-renewal of HSCs and their multi-lineage differentiation [14].
Mice carrying mutations in transcription factor genes have been important in distinguish-
ing lineage relationships between different cell types. Here, we used booreana mice to investi-
gate the lineage relationship between dendritic and myeloid subsets. It is generally well
established that conventional DCs (cDCs) develop from pre-cDCs [15] that derive from com-
mon dendritic progenitors (CDPs) in the bone marrow [16, 17]. Monocytes, on the other
hand, develop from CMPs in bone marrow, which then migrate into blood and tissues [18].
However, recent studies identify novel and distinct dendritic and myeloid subsets with unclear
lineage origin. For example, monocytes entering tissues were previously thought to differenti-
ate to give tissue macrophages [19]. Recent studies now report their derivation from yolk sac
progenitors, which makes them distinct from bone marrow-derived macrophages [20]. These
macrophages have been identified in several tissues and include liver Kuppfer cells, epidermal
Langerhans cells, and microglia [21–23]. Yolk sac-derived macrophages are F4/80hi and
depend on the PU.1 transcription factor for development, while monocytes/macrophages aris-
ing from HSPCs in bone marrow are dependent on c-Myb [20].
While most mutations in c-Myb are embryonic lethal, the single nucleotide mutation
E308G allows booreana mice to survive for several weeks [12]. Booreana can therefore be used
to measure the impact of c-Myb mutation on myelopoiesis in relation to specific cell subsets
and help identify their bone marrow origin. We analyzed mutant c-MybE308G mice alongside
WT mice in terms of numbers of hematopoietic progenitors in bone marrow, and dendritic
and myeloid cells in spleen. Since the in vivo effects of c-MybE308G on hematopoiesis are
Role of c-Myb in hematopoiesis
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complex [12], we first checked that the c-MybE308G mutational effect was intrinsic only to
hematopoietic cells and not somatic cells by comparing the cellular composition in boo/boo
versus WT chimeras. In addition, booreana mice were investigated as a possible source of
increased numbers of a rare splenic subset of endogenous dendritic-like cells, namely ‘L-DCs’,
that have been previously described by our lab [24, 25]. L-DCs were originally characterized as
the progeny of in vitro hematopoiesis involving defined subsets of LT-HSCs and MPPs from
bone marrow co-cultured above splenic stroma [26–28]. They have since been distinguished
as a clear subset within the spleen [24]. Booreana mice were therefore investigated as a possible
source of higher numbers of the L-DC subset, and perhaps more amenable for study of this
rare splenic subset.
Materials and methods
Animals
Specific pathogen-free female C57BL/6J (B6: CD45.2) and C57BL/6J.SJL (B6.SJL: CD45.1)
mice were bred at the John Curtin School of Medical Research (JCSMR) (Canberra, Australia).
Booreana (B6: c-MybE308G) mice were derived in an ENU mutagenesis breeding program
involving phenotypic screening of fetal liver cells for early hematopoietic abnormalities [12].
The strain was maintained by heterozygous (boo/+) breeding. Progeny were genotyped using
PCR to distinguish c-Myb and c-MybE308G by ear punch DNA in order to identify wild type
(WT), boo/+ and boo/boo progeny. Animal housing, handling and experimentation proce-
dures were approved by the Animal Experimentation Ethics Committee (Australian National
University, Canberra, Australia) under protocol #A2013/11. Animals were sacrificed by cervi-
cal dislocation. Pregnant mice for embryo extraction were euthanized using carbon dioxide.
Irradiation chimeras were generated by intravenous transfer of 2 x 105 or 1 x 106 fetal liver
cells of either boo/boo or WT origin (B6; CD45.2) into lethally irradiated (9.5 Gray) B6.SJL
(CD45.1) host mice. In addition, mice were given 2 x 106 supporting bone marrow cells of B6.
SJL x B6 F1 hybrid (CD45.1 x CD45.2) origin to ensure survival.
Preparation of cells
For analysis of blood composition, whole blood (175 μl) was collected from adult mice into
EDTA-treated tubes and run through an ADVIA 120/2120 Hematology System analyser (Sie-
mens AG, Munich, Germany). Cell suspensions of blood, bone marrow and spleen were also
prepared as described previously with removal of red blood cells (RBCs) by resuspension in
lysis buffer (140mM NH4Cl, 17mM Tris base in deionised water). Lineage-negative (Lin
-)
bone marrow was prepared using a lineage depletion cocktail (Miltenyi Biotech, Gladbach,
Germany) comprising biotinylated antibodies specific for all hematopoietic lineages (7–4,
CD5, CD11b, CD45R, Ly6G/C and Ter119), along with added antibody specific for CD11c to
deplete DCs (HL3: Becton Dickinson Pharmingen, San Diego, CA, USA). Column purification
of cells using MACS1 magnetic bead technology (Miltenyi Biotech) was utilized according to
the manufacturer’s protocol. Anti-biotin microbeads in MS or LS columns (Miltenyi Biotech)
were used to purify Lin- cells after the column was placed in a magnet (SuperMacs: Miltenyi
Biotec) and washing buffer passed through to collect flow-through cells. Splenocytes were also
depleted of T and B cells using MACS1 magnetic bead technology. Cells were incubated with
biotinylated antibodies specific for CD19 (B cells), Thy1.2 (T cells) and Ter119 (RBCs) (eBios-
ciences, San Diego, CA, USA) prior to separation using anti-biotin microbeads in columns as
described above.
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Antibody staining and flow cytometry
Fluorochrome-conjugated antibodies specific for CD11c (N418), CD11b (M1/70), CD115
(AFS98) and streptavidin-APC-Cy7 were obtained from eBiosciences or Bioloegend (San
Gabriel, CA, USA). Fluorochrome-conjugated antibodies specific for CD8α (53–6.7), B220
(RA3-6B2), MHC-II (AF6-120.1), CD3ε (145-2C11), c-kit (2B8), CD16/32 (Clone 93), Gr-1
(RB6-8C5), Sca1 (E13-161.7), CD34 (RAM34), IL-7Rγ (A7R34), Flt3 (A2F10), CD150 (TC15-
12F12.2), Ly6C (HK1.4), Ly6G (1A8), streptavidin-PE-Cy7, streptavidin-PE and streptavidin-
FITC were obtained from Biolegend. Goat-anti rat-PE-Texas Red was obtained from Invitro-
gen (Eugene, OR, USA). Isotype control antibodies including Rat IgG2a-FITC (R35-95), Rat
IgG2b-PE (RTK4530), Rat IgG2b-PE-Cy7 (eB149/10H5), Mouse IgG2a-biotin (eBM2a) and
Hamster IgG-APC (eBio299Arm) were obtained from eBiosciences.
Cells were stained as previously described [24, 28]. Briefly, 1 x 105–1 x 106 cells were incu-
bated with purified CD16/32 antibody (Clone 93; eBiosciences) for 15 min to block surface Fc
receptors. Cells were then washed with DMEM/1%FCS/0.1%NaN3 and stained with primary
antibodies for 20 min on ice. Any secondary reagents were added to the stained cells after a
washing step, and further incubated for 20 min on ice. Cells were washed twice and resus-
pended in DMEM/1%FCS/0.1%NaN3 for flow cytometric analysis using a LSRII flow cytome-
ter (Becton Dickinson). Cells were stained with PI (1μg/ml) for live cell discrimination. Gates
were set to delineate cell subsets using isotype control antibodies and ‘fluorescence minus one’
controls. Cell subset analysis was performed using BD FACSDiva Software (Becton Dickinson)
and FlowJo Software (Tristar; Phoenix, Arizona, USA).
Analysis of hematopoietic progenitors
Lin- bone marrow was prepared as described above and then stained with antibodies for delin-
eation of progenitors. The lineage depletion cocktail of antibodies (Miltenyi) supplemented
with antibody to CD11c, was used to identify Lin- cells. Staining for Sca-1 and c-kit was used
to delineate the Lin-Sca-1+ckit+ (LSK) subset [29]. LT-HSCs were then identified as the
CD150+Flt3- subset of LSK cells [30, 31]; MPPs as CD150-Flt3+ LSK cells [32]; macrophage
dendritic cell progenitors (MDPs) as Lin-Sca-1-c-kithiFlt3+CD115+ cells [33], and CDPs as
Lin-Sca-1-c-kitloFlt3+CD115+ cells [16, 17]. Cells were analysed by flow cytometry, isotype
control antibodies used to set gates and propidium iodide (PI: 1 μg/mL) staining of cells was
used for dead cell discrimination.
Establishment of co-cultures over splenic stroma
Cells were cultured as described previously [28] in Dulbecco’s Modified Eagles Medium
(DMEM) supplemented with 4 g/L D-glucose, 6 mg/L folic acid, 36 mg/L L-asparagine, 116
mg/L L-arginine, to which was added 10% fetal calf serum, 10mM HEPES, 2 mM L-glutamine,
100 U/L penicillin, 100 μg/L streptomycin, and 5 x 10−5 M 2-mercaptoethanol. The splenic
stromal cell line 5G3 was passaged every 4 days by scraping and transferring non-adherent
cells to a new flask [34]. Cells were maintained in 5% CO2 in 95% humidity at 37˚C.
For establishment of co-cultures, Lin- bone marrow (104−5 cells/ml) was overlaid on to
near-confluent 5G3 stroma in replicate 25 cm2 flasks (5 ml cultures). This procedure has been
described in detail previously [27, 28, 34, 35]. Medium change was performed every 3–4 days
by replacement of 2.5 ml medium. Non-adherent cells were collected at days 14, 21, and 28 for
analysis of dendritic and myeloid cells produced using antibody specific for CD11c, CD11b,
CD8α, B220 and MHC-II and flow cytometry.
Role of c-Myb in hematopoiesis
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Statistical analysis
Data were analyzed using the two-tailed Student’s t-test with significance determined at
p 0.05. For experiments involving only 3 or 4 replicates, significance was determined using
the Wilcoxon Rank Sum Text (p 0.05).
Results
Mutational effect of c-MybE308G is intrinsic to hematopoietic cells
Although booreana mice show multiple changes amongst hematopoietic cells, the mutation is
not lethal, with no loss of essential hematopoietic subsets [12]. In order to determine whether
the mutant phenotype was intrinsic to hematopoietic cells as opposed to an indirect or somatic
effect, fetal liver cells of boo/boo and WT mice were compared for their capacity to reconstitute
the hematopoietic compartment of chimeras. Lethally irradiated B6.SJL (CD45.1) mice were
reconstituted with boo/boo or WT fetal liver of B6 (CD45.2) origin, along with supporting
bone marrow cells from B6 x B6.SJL (CD45.2 x CD45.1) mice (S1 Fig). Two doses of test cells
were transplanted and reconstitution monitored by flow cytometric analysis of antibody-
stained peripheral blood leukocytes at 4-week intervals. The staining and gating procedure
used to analyze leukocyte subsets is shown in S2 Fig. The ADVIA machine was also used to
monitor cell composition of blood at 16 weeks.
A relative increase in myeloid cells and granulocytes compared with lymphoid cells was char-
acteristic of booreana mice. This was evident in the peripheral blood of boo/boo chimeras com-
pared with WT chimeras at 4, 8 and 12 weeks, although this increase was lost by 16 weeks (Fig 1,
S3 Fig). The early increase in myeloid cell numbers was balanced by a compensatory reduction
in B cell numbers but not T cell numbers, which reflected multiple changes in cell production in
the bone marrow (Fig 1, S3 Fig). After 16 weeks, boo/boo chimeras showed increased numbers of
T cells in peripheral blood, reduced numbers of B cells, and equivalent myeloid cell numbers
compared to WT chimeras. The increase in CD11b+ myeloid cells out to 12 weeks could reflect
an increase in both precursors and mature cells of the dendritic and macrophage/monocyte line-
ages emanating from higher numbers of bone marrow progenitors. A higher proportion of Gr1+
cells out to 12 weeks could reflect increased numbers of neutrophils and other granulocytes
entering the peripheral blood from bone marrow. These results indicated an important stimula-
tory role for c-MybE308G in myelopoiesis, with compensatory changes in T and B cell numbers.
Since significant changes were identified in the mature hematopoietic cell populations of boo/
boo chimeras compared to WT chimeras, it was clear that the c-MybE308G mutant phenotype was
intrinsic to the hematopoietic compartment and was not the result of an indirect change related
to the microenvironment in which HSCs develop. The mutation was not lethal and did not result
in the complete loss of one or more hematopoietic subsets.
Quantitation of cells in the blood of 16 week chimeras revealed that boo/boo chimeras had
significantly fewer white blood cells and neutrophils than WT chimeras (Fig 2). The average
number of these cells was reduced by ~3-fold due to the c-MybE308G mutation. A 2-fold increase
in platelet numbers in boo/boo chimeras over WT chimeras was evident, along with a reduced
production of mature red blood cells, but not reticulocytes. Consistent with this observation
was a reduction in hematocrit and hemoglobin levels (Fig 2). Blood analysis was consistent with
a reduction in both erythyropoiesis and granulopoiesis in boo/boo chimeras after 16 weeks.
Booreana bone marrow contains more hematopoietic progenitors
Since the c-MybE308G mutation effects myelopoiesis, we compared the bone marrow of adult
booreana mice with WT mice for known HSPC subsets. Bone marrow cells were isolated,
Role of c-Myb in hematopoiesis
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stained with antibody cocktails and viable (PI-) cells analysed flow cytometrically to delineate
subsets. Gates were used to detect Lin- cells, and then the subset of Lin-Sca1+ckit+ (LSK)
enriched for HSCs was identified. Further analysis employing three more markers–CD150,
Flt3, IL-7Rα –facilitated the gating of LT-HSCs, MPPs and CLPs (Fig 3A). Results shown in
Fig 3B reveal that bone marrow has a statistically significant increase in the number of
LT-HSCs and MPPs in boo/boo mice over WT mice, consistent with previous findings for fetal
liver [12]. Representation of CLPs in bone marrow was similar for boo/boo and WT mice, a
result which differed from previous fetal liver findings [12]. A 12-fold increase in the percent-
age of LT-HSCs in bone marrow is reflective of the booreana phenotype and consistent with c-
MybE308G impacting HSC self-renewal and proliferation.
Fig 1. In vivo reconstitution potential of booreana fetal liver HSCs. Chimeras were generated to investigate the in vivo reconstitution ability of booreana
(boo) versus WT fetal liver. Analyses involved a quantitative and kinetic study of the lineage potential of 1 x 106 (1M) or 2 x105 (200K) fetal liver cells from
boo/boo and WT mice of CD45.2 origin transplanted into lethally irradiated CD45.1 mice. Donor cell reconstitution was assessed via flow cytometric analysis
of subsets in peripheral blood of chimeras at 8 and 16 weeks post reconstitution. The proportional representation of T cells (CD3+), B cells (B220+), myeloid
cells (CD11b+) and granulocytes (Gr1+) was measured within the donor-derived (CD45.2) leukocyte compartment of peripheral blood. Individual data points
are shown, with mean value indicated by a horizontal bar. All comparisons between equivalent boo/boo and wild type chimeras were significantly different
(p 0.05) except for T cells at 8 weeks, and macrophages and granulocytes at 16 weeks. More complete data at 4, 8, 12 and 16 weeks are summarised in
S3 Fig. Significantly different data sets are shown by *.
https://doi.org/10.1371/journal.pone.0176345.g001
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In terms of dendritic and myeloid cell progenitors, the more recently defined CDP and
MDP subsets in bone marrow were investigated since these were found to be responsible for
repopulation of dendritic and myeloid subsets in spleen [11, 36]. Lin- bone marrow cells were
first gated, and the Sca1- subset divided on the basis of c-kit expression. The c-kithi subset was
further divided by expression of Flt3 and CD115 to delineate the described MDP population
[33], while the c-kitlo subset of Flt3+CD115+ cells was gated to represent CDPs [11] (Fig 4A).
Both boo/boo and WT bone marrow contained subsets of MDPs and CDPs, although boo/boo
mice showed a significantly higher proportion of both progenitor subsets (Fig 4B), which was
in line with higher numbers of the earlier HSC and MPP subsets (Fig 3B). This increase sug-
gested higher potential for myelopoiesis and DC development in the bone marrow of boo/boo
mice, and was consistent with increased myelopoiesis in the peripheral blood of chimeras out
to 12 weeks (Fig 1).
Reduced numbers of late myeloid progenitors in booreana bone marrow
Oligopotent late myeloid progenitors have been described as able to differentiate to give sev-
eral myeloid lineages [37]. The frequency of the described CMPs, GMPs, and myelo-erythroid
progenitors (MEP) was therefore compared in boo/boo and WT bone marrow. Lin- bone
Fig 2. Peripheral blood analysis of chimeras reconstituted with booreana fetal liver. Chimeras were prepared as described in Fig 1. At 16-weeks post-
transplant, blood composition was analyzed. Individual data points are shown for boo/boo and WT chimeras, with the mean value indicated by a horizontal
bar. All comparisons between equivalent boo/boo and wild type chimeras were significantly different (p 0.05), except for reticulocyte counts in chimeras
reconstituted with 1 x 106 cells. HGB = hemoglobin, HCT = hematocrit, RBC = red blood cells, WBC = white blood cells. Significantly different data sets are
shown by *.
https://doi.org/10.1371/journal.pone.0176345.g002
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Fig 3. Analysis of bone marrow progenitors in booreana (boo/boo) and WT mice. Bone marrow from adult mice was prepared and stained with
antibodies to distinguish hematopoietic progenitors flow cytometrically. A lineage cocktail of antibodies was used to gate Lin- subsets, and Sca-1 and
c-kit staining used to identify the Lin-c-kit+Sca-1+ (LSK) subset. Staining for Flt3 and CD150 was used to distinguish LT-HSCs and MPPs, and
staining for IL-7R and Flt3 was used to distinguish CLPs. Propidium iodide (PI; 1 μg/ml) staining was used to gate live cells as PI-. Gates were set on
bivariate plots using isotype control antibodies, and numbers in gates reflect % positive cells amongst Lin-PI- bone marrow cells. (A) Staining profiles
for representative individual mice are shown. (B) Percent cells amongst viable Lin- bone marrow is shown for 3 individual mice, with mean shown by
a bar and statistically significant results (p 0.05) boxed in red.
https://doi.org/10.1371/journal.pone.0176345.g003
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marrow was gated, followed by delineation of Sca-1- cells with high c-kit expression. This sub-
set was then divided on the basis of CD34 and CD16/32 expression to give CMPs, GMPs, and
MEPs (Fig 5A). Boo/boo mice showed a slight but significant reduction in CMPs, and a signifi-
cant 2-fold reduction in GMPs in relation to WT mice (Fig 5B). These results contrasted
Fig 4. Booreana (boo/boo) mice have increased numbers of dendritic cell progenitors in bone marrow. Cells from boo/boo and WT mice were
prepared and stained with antibodies to distinguish macrophage dendritic cell progenitors (MDP) and common dendritic cell progenitors (CDP) flow
cytometrically. A lineage cocktail of antibodies was used to gate the Lin- cells and so exclude mature cells. Sca-1 and c-kit staining was used to identify the
Lin-c-kithiSca-1- and Lin-c-kitloSca-1- subsets, and staining for Flt3 and CD115 used to distinguish MDP and CDP amongst these subsets. Propidium iodide
(PI; 1 μg/ml) staining was used to gate live cells (PI-). Gates were set on bivariate plots using isotype control antibodies, and numbers in gates reflect %
positive cells amongst Lin-PI- bone marrow cells. (A) Profiles for representative individual mice are shown. (B) Percent cells amongst viable Lin- bone
marrow is shown for 3 individual mice, with mean value shown as a bar, and statistically significant results (p 0.05) boxed in red.
https://doi.org/10.1371/journal.pone.0176345.g004
Role of c-Myb in hematopoiesis
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sharply with the increased representation of earlier progenitors in boo/boo mice (Fig 3). The
proportion of MEPs did not differ significantly between boo/boo and WT mice, a result consis-
tent with only minor changes in RBCs, reticulocyte and hemacrit counts in boo/boo compared
with WT chimeras (Fig 2). However, previous studies on fetal liver showed lower numbers of
GMPs and MEPs in boo/boo mice compared with WT mice [12].
Effect of c-MybE308G on myelopoiesis in spleen
We next investigated the impact of the c-MybE308G mutation on the development of individual
dendritic and myeloid subsets in spleen. In particular, the impact of MybE308G on L-DC pro-
duction was of interest given the discovery that this novel subset develops from hematopoietic
progenitors endogenous to spleen [38]. Initially, the total population of myeloid and dendritic
cells (CD11c+ and/or CD11b+) was quantitated in spleens of boo/boo and WT chimeras at 52
weeks post reconstitution. The production of these chimeras was described in S1 Fig and S2
Fig. Overall, boo/boo chimeras showed a significant 2-fold greater population of dendritic/
myeloid cells in spleen than did WT chimeras (Fig 6A). While boo/boo and WT chimeras
showed equivalent representation of myeloid cells and granulocytes in blood at 16 weeks (Fig
1), boo/boo chimeras showed higher numbers than WT chimeras after 52 weeks. Over the
long-term, c-MybE308G had the effect of increasing myelopoiesis.
An investigation of spleen in adult mutant mice is possible since the c-MybE308G mutation
is not embryonically lethal and boo/boo mice live to adulthood. Further studies therefore in-
vestigated the effect of c-MybE308G on the representation of individual dendritic and myeloid
subsets in spleen. Individual mice were analyzed, and cells stained to detect mature subsets
of CD8+ cDCs (CD11chiCD11b-MHCII+CD8+) and CD8- cDCs (CD11chiCD11bloMH-
CII+CD8-). In a separate staining, subsets of L-DCs (CD11cloCD11bhiLy6C-Ly6G-), resident
monocytes (CD11bhiCD11clo/-Ly6C+Ly6G-), inflammatory monocytes (CD11bhiCD11c-Ly6-
ChiLy6G-) and neutrophils (CD11bhiCD11c-Ly6C+Ly6G+) were also quantitated within the
total spleen population of dendritic and myeloid cells. Of the DC subsets, only CD8- cDCs
were found to be significantly reduced in number in boo/boo compared with WT mice.
Among the myeloid subsets, both inflammatory monocytes and neutrophils were significantly
reduced, but not resident monocytes. The representation of CD8+ cDCs and L-DCs did not
differ between boo/boo and WT mice. The mutational effect of c-MybE308G on subset size
served to distinguish L-DC from CD8- cDCs, and inflammatory monocytes from resident
monocytes, consistent with a distinct lineage origin for these subsets.
The increased representation of CD11c+ and/or CD11b+ cells in peripheral blood (Fig 1)
and spleen (Fig 6A) of boo/boo chimeras was not supported by an increase in the representa-
tion of carefully defined mature dendritic and myeloid cells in boo/boo adult spleen (Fig 6B).
Measurement of CD11b+ cells in blood (Fig 1), and of CD11c+/CD11b+ cells in spleens of boo/
boo chimeras (Fig 6A) includes precursors pouring out of bone marrow into blood and spleen,
and will not accurately reflect numbers of mature cells in these organs. Increased myelopoiesis
in boo/boo mice would therefore appear to reflect the production of more immature myeloid
cells. Production of mature cells in spleen would be limited by available microenvironments
and competition for empty niche spaces. The production of CD8+ cDCs, L-DCs, and resident
monocytes was unaffected by c-MybE308G, while the production of inflammatory monocytes,
neutrophils, and CD8- cDCs was reduced.
Assessment of L-DC progenitors in bone marrow
Previous studies have shown that the spleen contains progenitors of L-DCs that seed spleen
stromal co-cultures to produce this novel dendritic-like subset [39–41]. A number of studies
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now equate L-DC progenitors with LT-HSC and MPP subsets in bone marrow, fetal liver, and
spleen [26, 28, 38]. In order to compare the prevalence of L-DC progenitors in boo/boo versus
Fig 5. Booreana (boo/boo) mice show a reduction in myeloid progenitors in bone marrow. Cells from boo/boo and
WT mice were prepared and stained with antibodies to distinguish hematopoietic progenitors flow cytometrically. A lineage
cocktail of antibodies was used to gate the Lin- subsets, so excluding mature cells. Sca-1 and c-kit staining was used to
identify the Lin-c-kit+Sca-1+ subset. Staining for CD34 and CD16/32 was used to distinguish CMPs, GMPs, and MEPs.
Propidium iodide (PI; 1 μg/ml) staining was used to gate live cells (PI-). Gates were set on bivariate plots using isotype
control antibodies, and numbers in gates reflect % positive cells amongst Lin-PI- bone marrow cells. (A) Profiles for
representative individual mice are shown. (B) Percent cells amongst viable Lin- bone marrow is shown for 3 individual mice,
with mean value shown as a bar, and statistically significant results (p 0.05) boxed in red.
https://doi.org/10.1371/journal.pone.0176345.g005
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Fig 6. Analysis of splenic myeloid and DC subsets in booreana versus WT mice. (A) Chimeras were prepared as described in Fig 1 and
sacrificed at 52 weeks. The total splenic dendritic and myeloid subset was purified via red blood cell lysis and T/B cell depletion. Cells were stained
with antibody to detect CD45.2+ cells, and the population gated as CD11b+ and/or CD11c+ to estimate % dendritic/myeloid cells, respectively.
Data represent mean ±SE (n = 4), and p values for statistically significant pairs of data shown. (B) Spleens of adult booreana and WT mice were
enriched for DC and myeloid cells via red blood cell lysis and T/B cell depletion. Cells were then stained with antibodies to delineate subsets of
CD8+ cDCs (CD11chiCD11b-MHCII+CD8+), CD8- cDCs (CD11chiCD11bloMHCII+CD8-), L-DCs (CD11cloCD11bhiLy6C-Ly6G-), resident
monocytes (resi mono: CD11bhiCD11clo/-Ly6C+Ly6G-), inflammatory monocytes (infl mono: CD11bhiCD11c-Ly6ChiLy6G-), and neutrophils (neu:
CD11bhiCD11c-Ly6C+Ly6G+). The proportional representation of each subset was calculated relative to the total dendritic and myeloid population
in spleen (i.e. CD11b+ and/or CD11c+ cells, respectively). Data (mean) are shown for boo/boo (n = 3) and WT (n = 4) mice. Statistically significant
findings (p 0.01) are boxed and p values are shown.
https://doi.org/10.1371/journal.pone.0176345.g006
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WT mice, Lin- bone marrow was prepared and seeded into splenic stromal co-cultures as pre-
viously described [27, 34, 35]. To avoid the influence of environment on development of L-DC
progenitors, bone marrow was isolated from chimeras described in Fig 1 and S1 Fig. Cells
were sorted on the basis of lineage and CD45.2 expression to yield Lin- bone marrow of boo/
boo and WT origin from individual chimeras, each having a CD45.1 WT background (S1 Fig).
Equal numbers of cells were then co-cultured above 5G3 stroma, and the relative capacity of
boo/boo and WT bone marrow progenitors was compared for myelopoiesis and L-DC
production.
Non-adherent cells were collected over time and stained with specific antibodies for the
identification and quantitation of cell subsets using flow cytometry as previously described
[27, 28]. Co-cultures established with both boo/boo and WT Lin- bone marrow were each
produced greater numbers of L-DC (CD11b+CD11c+MHC-II-CD8-B220-) than cDC-like
cells (CD11b+CD11c+MHC-II+CD8-B220-) (Fig 7A); these are the two subsets known to be
produced in Lin- bone marrow co-cultures over 5G3 [27]. After 28 days, co-cultures estab-
lished with boo/boo Lin- bone marrow yielded significantly higher numbers of both L-DC
and cDC-like progeny than WT (Fig 7B). It was previously found that the L-DC progenitor
was contained within subsets of LT-HSCs and MPPs [28], while the progenitor of cDC-like
cells was contained within CDP and MDP subsets [28]. These results are consistent with evi-
dence for higher numbers of these progenitors in boo/boo over WT bone marrow (Figs 3B
and 4B).
As with all previous 5G3 co-culture studies involving overlaid hematopoietic progenitors,
only myelopoiesis or DC development was detected in either boo/boo or WT type co-cultures,
with no production of lymphoid cells or DC subsets expressing markers like CD8+ or B220+
[42–44]. L-DC production was maintained by co-cultures established with both boo/boo and
WT bone marrow for up to 6 months (data not shown), which was consistent with all previous
studies on in vitro hematopoiesis with L-DC production [26, 34, 42].
Discussion
In this paper, we used flow cytometry to detail changes in hematopoiesis due to the c-MybE308G
mutation in mice. Changes in the representation of dendritic and myeloid cells present in
blood and spleen were compared with changes in the production of progenitors of these line-
ages in bone marrow. Investigations were aimed at detecting coincident changes which sup-
ported a common role for the c-MybE308G mutation in cell lineage development. In chimera
studies, the effect of the c-MybE308G mutation was also found to be intrinsic to hematopoietic
cells and not somatic cells, which was consistent with the known function of c-Myb in control-
ling hematopoiesis in bone marrow. A similar finding was also reported for the c-MybM303V
mutant strain [9]. The interpretation of subset data in vivo is not straightforward and has to
consider compensatory effects when one subset is repressed and others increase to fill tissue
spaces. In chimeras, there is also the effect of competition between boo/boo and WT progeni-
tors to seed niches for hematopoiesis.
The c-Myb308G mutation was found to impact hematopoietic cell development in a complex
way, mapping to early HSPC expansion with less development of some mature cell types
including CD8- cDCs, inflammatory monocytes, and neutrophils. This mutation had little
effect on the development of CD8+ cDCs, resident monocytes, and L-DCs. It clearly showed
differential effects on inflammatory versus resident monocytes, and on L-DCs versus CD8-
cDCs. The c-MybE308G mutation therefore served to distinguish the lineage origin of these two
monocyte subsets, as well as some DC subsets. A summary diagram of the effects detected here
is shown in Fig 8.
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Fig 7. Hematopoiesis due to booreana (boo/boo) and WT bone marrow in co-cultures. Bone marrow was
prepared from one-year old chimeras described in Fig 1. Donor-derived CD45.2+ bone marrow cells were sorted as
a Lin- population of boo/boo or WT origin, and equal numbers co-cultured over 5G3 splenic stroma. Individual co-
cultures were established from 4 boo/boo chimeras and 2 WT chimeras. Cell production was monitored over time by
staining non-adherent cells using antibodies to CD11c, CD11b, MHC-II, and CD8α, or with isotype controls.
Propidium iodide (PI; 1 μg/ml) staining was used to gate live cells (PI-). Gates were set on bivariate plots using
isotype control antibodies, and numbers shown in gates reflect % positive cells. (A) Data shows staining of 21 day
co-cultures established from one of each chimera type. L-DCs were gated as CD11cloCD11bhiMHC II-CD8α-B220-
cells, and cDC-like cells as CD11chiCD11bloMHC II+CD8α-B220-. (B) Cell production was calculated and shown as
mean ± SE for co-cultures established from boo/boo (n = 4) and wild-type (WT) (n = 2) chimeras. Significantly
different data pairs are indicated.
https://doi.org/10.1371/journal.pone.0176345.g007
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Mutant c-Myb308G mice were also useful for distinguishing the lineage origin of dendritic
and myeloid subsets in spleen [10, 46]. Recent studies have indicated that some tissue macro-
phages in spleen develop from yolk sac-derived progenitors endogenous to spleen, while other
monocytes/macrophages develop from bone marrow-derived progenitors [47]. Data shown
here indicate at least two lineages of macrophages/monocytes since the production of inflam-
matory monocytes in spleen was reduced due to mutation in c-Myb, while production of resi-
dent monocytes was not. Resident monocytes may develop from progenitors which do not
originate in bone marrow. The data are also consistent with L-DC development being c-Myb-
independent, involving endogenous progenitors in spleen, perhaps of yolk sac origin, while
CD8- cDCs arise from c-Myb-dependent progenitors arising in bone marrow. This result is
consistent with previous findings that L-DCs are developmentally distinct from cDCs, with
only L-DC and not cDC arising in a Flt3-ligand- and GM-CSF-independent manner [48].
These findings support the possibility that L-DCs and resident monocytes in spleen arise from
progenitors that are not bone marrow-derived and may be endogenous to spleen as yolk sac-
derived hematopoietic progenitors. Whether L-DCs and resident monocytes are related in
terms of lineage is currently unknown.
In terms of early hematopoiesis, our comprehensive analysis of booreana mice showed
increased production of more primitive self-renewing HSPCs including subsets of LT-HSCs,
ST-HSCs and MPPs in bone marrow, which was a result previously reported for fetal liver
[12]. However, in contrast to fetal liver, the bone marrow of booreana mice showed no change
in CMP and CLP populations. Since these are more committed hematopoietic progenitors, the
question arises as to whether CLPs and CMPs in fetal liver have the same differentiative poten-
tial as their equivalents in adult bone marrow. Indeed, the c-MybE308G mutation appeared to
enhance the self-renewal capacity of progenitors and inhibit their differentiative capacity since
CMPs, GMPs and MEP were all reduced in number, with the greatest reduction being in
GMPs. A reduction in myeloid lineage progenitors was also reflected by a decrease in the num-
ber of mature myeloid lineage cells including granulocytes and inflammatory monocytes (Figs
1 and 6).
In stromal co-cultures supporting in vitro hematopoiesis, L-DC have been shown to arise
directly from early hematopoietic progenitors. This conclusion was reached in a study using
IkarosPlastic homozygous mutant mice which live to only E15.5 but produce HSCs after E12.5
which lack self-renewal capacity, and no other hematopoietic progenitors [49]. While WT
E14.5 progenitors seeded co-cultures and produced L-DC out to 28 days, fetal liver HSCs from
E14.5 IkarosPlastic mutant mice were able to give short-term production of L-DC across days 7
and 14 of co-culture [50]. This result was interpreted to reflect direct differentiation of L-DCs
from HSCs. L-DCs can also arise in stromal co-cultures from progenitors isolated from spleen
[39–41], as well as HSC and MPP subsets sorted from fetal liver [26] and bone marrow [27,
28]. The increased numbers of LT-HSCs and MPPs in the bone marrow of booreana over WT
mice needs to be considered in terms of L-DC development since both bone marrow-derived
LT-HSCs and MPPs were previously shown to contain L-DC progenitors [28]. Increases of up
to 8-fold for LT-HSCs and ~6-fold for MPPs in bone marrow suggest strong deregulation of
hematopoietic development in c-MybE308G mutant mice. These changes, however, related to
bone marrow specifically since L-DC numbers in spleens of mutants were found to be main-
tained at WT levels (Fig 6). This would be consistent with their c-Myb independent develop-
ment from yolk sac-derived progenitors present in spleen in the normal steady-state mouse.
An investigation into the development of DC lineages also showed increases of 4-5-fold in
numbers of CDPs and MDPs in booreana over WT mice. In line with evidence that c-
MybE308G imposes increased self-renewal of HSPCs, these two progenitor subsets now seem
more aligned with the development of MPPs and LT-HSCs, and quite distinct from the more
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committed CMP and GMP populations. Indeed, this information is consistent with a separate
dendritic lineage of cells, distinct from the myeloid lineage. It is possible that the MDP progen-
itor is therefore mixed and leads to the separate development of a self-renewing CDP, which
then seeds the development of conventional and plasmacytoid DC, and a CMP that seeds
development of monocytes/macrophages, granulocytes, and erythroid lineages. CDP and
MDP are unique to bone marrow, while the subsequent development of cDCs occurs in spleen
from incoming pre-cDCs [15]. As with L-DC development from LT-HSCs and MPPs, the
increase in CDP (and MDP) numbers in bone marrow did not coincide with an increase in
total cDC numbers (CD8+ and CD8- subsets) in spleen. Other environmental or regulatory
factors must therefore determine the population size of mature cDCs that develop in spleen.
Both the c-MybE308G mutant mouse studied here and the c-MybM303V mutant described by
Sandberg et al [9] contain a mutation in the transactivating region of c-Myb which interacts
with the coactivator P300. However, the two mutant strains do not give completely consistent
phenotypes. There are effects common to the two strains, and some distinct effects. For exam-
ple, LT-HSC are increased in number by ~10 fold in both mutants and this has been attributed
Fig 8. Changes in hematopoiesis attributable to the c-Myb308G mutation. The summary diagram combines analysis of stem/progenitor subsets in
mutant mouse bone marrow, with subset analysis of mature cell subsets in blood and spleen of chimeras reconstituted with mutant fetal liver cells and
analysed at 16 weeks after reconstitution. Significant changes in cell production in relation to wild type mice or wild type control chimeras are shown in red
indicating increase, or blue indicating a decrease, in cell production. Subsets unchanged in mutant and wild type are shown in grey. The diagram is not a
complete lineage map since only subsets analysed are shown. These include: LT-HSC, longterm hematopoietic stem cell; MPP, multipotential progenitor;
CMP, common myeloid progenitor; CLP, common lymphoid progenitor; MDP, myeloid dendritic progenitor; CDP common dendritic progenitor; MEP,
myeloid/erythroid progenitor; GMP, granulocyte/macrophage progenitor. The lineage relationship between the MDP subset and CMP and CDP is shown
as a dashed line since it is still in doubt [45]]. Similarly, the derivation of L-DC directly from bone marrow HSC and MPP is shown as a dashed line, since
this has only been confirmed in vitro [28].
https://doi.org/10.1371/journal.pone.0176345.g008
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to an increase in the autonomous proliferative capacity of mutant LT-HSC [9]. In both studies,
CLP numbers remain almost unchanged, erythyrocytes are reduced by ~1.2 fold, platelets are
increased by 2-fold, and B cell numbers are reduced by 4–5 fold. However, several distinct
effects are seen. The E308Gmutation studied here is associated with 4–5 fold increases in num-
ber of MDP and CDP, reduced numbers of CMP and GMP, neutrophils and inflammatory
monocytes, and a small increase in T cell production. In contrast the M303V mutation shows
reduced numbers of MEP and CMP, no change in GMP, MDP and CDP numbers, no change
in neutrophils, basophils or monocytes, while T cell numbers are reduced dramatically by 4–5
fold. The two mutants differ most noticeably in terms of development of T cells versus myeloid
cells. The two strains have however not been compared in the same experiment, and estimates
of cell subsets will always be dependent on the criteria or antibodies used to detect cells.
Both the c-MybM303V and the c-MybE308G mutant mouse strains contain a mutation in the
transactivating region of c-MYB which interacts with the coactivator P300. In the case of
homozygous c-MybM303V mice, Sandberg et al [9] have shown transactivation capacity to be
reduced to ~50% of wild type animals. This leaves open the possibility that the E308G mutation
may have different capacity to bind P300, and different transactivation capacity, which could
differentially affect the production of cells in any hematopoietic pathway dependent on c-Myb.
Indeed c-Myb is known to have multiple effects acting on both stem cells and later stages of
hematopoiesis [12].
Conclusion
Despite major disturbance among the early hematopoietic progenitors in bone marrow, and
also among mature myeloid and erythroid cell types, booreana mice displayed no disturbance
in the presence or prevalence of L-DCs in spleen. This result was consistent with their develop-
ment from progenitors that were c-Myb-independent and were not bone marrow-derived
hematopoietic progenitors.
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S1 Fig. Schematic showing the production of chimeras using booreana and WT fetal liver.
Lethally irradiated (9.5 Gray) CD45.1+ host mice were transplanted with either 1 x 106 (1M) or
2 x 105 (200K) fetal liver cells from either boo/boo or WT mice of CD45.2+ origin. In addition,
2 x 106 (2M) supporting BM cells of F1 (CD45.1 x CD45.2) origin were given to each host.
Flow cytometric profiles used to distinguish host and donor origin cells are shown.
(PPTX)
S2 Fig. Flow cytometric gating strategy used to identify mature progeny of donor cells.
Donor cell reconstitution was assayed by staining TER119- CD45.2+ peripheral blood cells for
markers of mature hematopoietic cells (CD3, B220, Mac1, Gr-1) monthly until to 16 weeks
post transplantation.
(PPTX)
S3 Fig. In vivo reconstitution potential of booreana fetal liver HSC. Mouse chimeras were
generated as described in S1 Fig to investigate the in vivo reconstitution ability of booreana
(boo) versus wild-type (WT) fetal liver. The lineage composition of the reconstituted compart-
ment of peripheral blood from donor 1 x 106 (1M) or 2 x 105 (200K) fetal liver cells from either
boo/boo or WT mice of CD45.2+ origin is shown as a kinetic (monthly) measure post-trans-
plantation.
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